PIK3CA and endometrial cancer: The results showed that the disease control rate (DCR) was 12.5% and 40.0% in patients with PI3KCA-wt and PIK3CA-m in ovarian cancer, 47.1% and 14.3% in endometrial cancer, 11.1% and 25.0% in cervical cancer.